Evidence map›Paper›PMID 25667327›Full record

ArticleThe Journal of general virology2015

Permissivity of primary hepatocytes and hepatoma cell lines to support hepatitis C virus infection.

Garrick K Wilson, Michelle J Farquhar, Luke Meredith, Anil Dhawan, Ragai Mitry, Peter Balfe, Jane A McKeating

Abstract read
In one paragraph

Article in The Journal of general virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Garrick K WilsonInstitute for Biomedical Research and NIHR Liver Biomedical Research Unit, Centre for Human Virology, Viral Hepatitis Laboratory, University of Birmingham, Birmingham B15 2TT, UK.
Michelle J FarquharInstitute for Biomedical Research and NIHR Liver Biomedical Research Unit, Centre for Human Virology, Viral Hepatitis Laboratory, University of Birmingham, Birmingham B15 2TT, UK.
Luke MeredithInstitute for Biomedical Research and NIHR Liver Biomedical Research Unit, Centre for Human Virology, Viral Hepatitis Laboratory, University of Birmingham, Birmingham B15 2TT, UK.
Anil DhawanInstitute of Liver Studies, Kings College Hospital and Kings College London, London SE5 9RS, UK.
Ragai MitryInstitute of Liver Studies, Kings College Hospital and Kings College London, London SE5 9RS, UK.
Peter BalfeInstitute for Biomedical Research and NIHR Liver Biomedical Research Unit, Centre for Human Virology, Viral Hepatitis Laboratory, University of Birmingham, Birmingham B15 2TT, UK.
Jane A McKeatingInstitute for Biomedical Research and NIHR Liver Biomedical Research Unit, Centre for Human Virology, Viral Hepatitis Laboratory, University of Birmingham, Birmingham B15 2TT, UK.

Funding

Medical Research Council G0400802Medical Research Council G0801976Medical Research Council G1100247Medical Research Council MR/J006742/1
6 · The paper itself

Abstract

The major cell type supporting hepatitis C virus (HCV) infection is the hepatocyte; however, most reports studying viral entry and replication utilize transformed hepatoma cell lines. We demonstrate that HCV pseudoparticles (HCVpp) infect primary hepatocytes with comparable rates to hepatoma cells, demonstrating the limited variability in donor hepatocytes to support HCV receptor-glycoprotein-dependent entry. In contrast, we observed a 2-log range in viral replication between the same donor hepatocytes. We noted that cell proliferation augments pseudoparticle reporter activity and arresting hepatoma cells yields comparable levels of infection to hepatocytes. This study demonstrates comparable rates of HCVpp entry into primary hepatocytes and hepatoma cells, validating the use of transformed cells as a model system to study HCV entry.

Indexed as

Viral TropismCells, CulturedHepacivirusHepatocytesHumansVirus InternalizationVirus Replication

Identifiers

PMID25667327
PMCPMC4635487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.